Bonus BioGroup

Bonus BioGroup is a product-focused biotechnology company applying proprietary technology to supply tissue-regenerating, viable bone grafts. It develops cell therapy and tissue-engineering products based on autologous bone implants that enable efficient bone transplantation and provide cell-based bone replacement for repairing bone lesions. Bonus BioGroup developed BonoFill, a method to grow 3D, high-density bone grafts based on multi-cell 3D cultures. BonoFill is derived from the patient’s own cellsand constructed froma variety of cells grown in multi-layers within a bioreactor system. This technology enables construction of the bone graft outside of the human body (ex vivo) and promotes graft acceptance by the patient’s body following transplantation. It also allows growth of a human tissue graft tailored to the biological, physical, and clinical needs of each patient, without invoking immune reactions or graft rejection.